Skip to main content
European Commission logo print header

Cardiovascular Risk from Exposure to Low-dose and Low-dose-rate Ionizing Radiation

Obiettivo

Epidemiological evidence has established a link between cardiovascular disease and exposure of the heart and major vessels to doses above 500mGy. At lower doses the evidence for a detrimental effect is inconclusive. In part, this is due to the lack of appropriate epidemiological studies, coupled with lack of knowledge of the processes involved that is needed for construction of mathematical models. The ProCardio consortium will study cardiovascular outcomes in childhood cancer survivors where the radiation doses given to the heart are available. These data will be interrogated using new mathematical models developed from the data from our molecular and biological studies. These will use state-of-the-art technologies to map cardiovascular changes after photon irradiation at both low doses and low dose rates. This will be complemented by comparative studies using high LET irradiation. We will apply an integrative approach to combine transcriptional (mRNA and miRNA) and translational (proteomics) studies to understand the disease processes. High throughput proteomics (ICPL, SILAC and label-free analysis) will be used to identify new biomarkers of radiation-induced cardiovascular disease for future molecular epidemiological studies. These will be validated using the archives of cardiovascular tissue samples from the Mayak facility.

Invito a presentare proposte

FP7-Fission-2011
Vedi altri progetti per questo bando

Coordinatore

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Contributo UE
€ 679 796,00
Indirizzo
INGOLSTADTER LANDSTRASSE 1
85764 Neuherberg
Germania

Mostra sulla mappa

Regione
Bayern Oberbayern München, Landkreis
Tipo di attività
Research Organisations
Contatto amministrativo
Jürgen Ertel (Dr.)
Collegamenti
Costo totale
Nessun dato

Partecipanti (12)